Summit Hotel Properties, Inc. (SDP.F)
| Previous Close | 5.40 |
| Open | 5.30 |
| Bid | 5.60 x 28100 |
| Ask | 5.70 x 27200 |
| Day's Range | 5.30 - 5.60 |
| 52 Week Range | 4.96 - 6.25 |
| Volume | |
| Avg. Volume | 10 |
| Market Cap | 612.808M |
| Beta (5Y Monthly) | 2.03 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.22 |
| Earnings Date | Jul 29, 2024 |
| Forward Dividend & Yield | 0.30 (5.47%) |
| Ex-Dividend Date | May 16, 2024 |
| 1y Target Est | 11.50 |
CNW GroupInnocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA's Center for Veterinary Medicine (CVM) has granted the Company a sponsor fee waiver and assigned an Investigational New Animal Drug (INAD) number for its LPT-CBD (Liposome Platform Technology-Cannabidiol) product. This represents a significant step for the Company, as an INAD designation facilitates corres
PR NewswireSUMMIT HOTEL PROPERTIES DECLARES SECOND QUARTER 2024 DIVIDENDS
Summit Hotel Properties, Inc. (NYSE: INN) (the "Company"), announced today that its Board of Directors has authorized, and the Company has declared, a cash dividend for the second quarter ended June 30, 2024, of $0.08 per share of common stock of the Company and per common unit of limited partnership interest in Summit Hotel OP, LP, the Company's operating partnership. The Company's second quarter common dividend represents an annualized dividend yield of 5.4 percent based on the closing price o
ZacksIs Summit Hotel Properties (INN) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
